News ESSA Pharma Inc. Toronto S.E.

Equities

CA29668H7085

End-of-day quote Toronto S.E. Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-.--%	-.--%

20/05	Top Premarket Decliners	MT
14/05	ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ESSA Pharma to Present at the Jefferies Global Healthcare Conference	30/05	PR
ESSA Pharma to Present at the Jefferies Global Healthcare Conference	30/05	AQ
Top Premarket Decliners	20/05	MT
ESSA Pharma: Fiscal Q2 Earnings Snapshot	14/05	AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024	14/05	PR
ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	14/05	CI
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	09/04	PR
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	08/03	PR
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	08/03	AQ
Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call	07/03
Norway's wealth fund pushes for more women on emerging market company boards	06/03	RE
ESSA Pharma : Passive Foreign Investment Company Statement	28/02	PU
ESSA Pharma: Fiscal Q1 Earnings Snapshot	13/02	AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023	13/02	AQ
ESSA Pharma Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	13/02	CI
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02	PR
ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	26/01	AQ
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	25/01	PR
ESSA Pharma: Fiscal Q4 Earnings Snapshot	12/12	AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023	12/12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ESSA Pharma Inc. Toronto S.E.

Equities

CA29668H7085

Summary

Filters